Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 18.17% is 13% below its 5-year average of 20.87%, near the low end of its 5-year range (17.85%–23.46%).
0.33% above its 12-month average of 18.11%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 18.53%.
GROSS MARGIN
18.17%
GROSS MARGIN AVG TTM
18.11%
GROSS MARGIN AVG 3Y
19.92%
GROSS MARGIN AVG 5Y
20.87%
GROSS MARGIN AVG 10Y
24.54%
GROSS MARGIN AVG 15Y
26.36%
GROSS MARGIN AVG 20Y
23.14%
CURRENT VS TTM AVG
+0.33%
CURRENT VS 3Y AVG
-8.78%
CURRENT VS 5Y AVG
-12.92%
CURRENT VS 10Y AVG
-25.97%
CURRENT VS 15Y AVG
-31.06%
CURRENT VS 20Y AVG
-21.48%
SECTOR MEDIAN · HEALTHCARE
39.56%
median of 701 covered companies
CURRENT VS SECTOR MEDIAN
-54.07%
vs the sector median at left
Option Care Health, Inc.
Market Cap
$4.65B
Gross Margin
18.17%
TTM Avg
18.11%
3Y Avg
19.92%
5Y Avg
20.87%
Market Cap
$4.62B
Gross Margin
71.27%
TTM Avg
60.67%
3Y Avg
48.49%
5Y Avg
48.49%
Market Cap
$4.70B
Gross Margin
33.56%
TTM Avg
32.27%
3Y Avg
30.18%
5Y Avg
31.09%
Market Cap
$4.74B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.45B
Gross Margin
75.44%
TTM Avg
66.98%
3Y Avg
64.58%
5Y Avg
67.25%
Market Cap
$4.44B
Gross Margin
83.86%
TTM Avg
80.36%
3Y Avg
82.01%
5Y Avg
82.83%
Market Cap
$4.86B
Gross Margin
96.01%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
83.33%
Market Cap
$4.86B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.38B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Option Care Health, Inc. (OPCH) | $4.65B | 18.17% | 18.11% | 19.92% | 20.87% |
| BillionToOne, Inc. (BLLN)vs › | $4.62B | 71.27% | 60.67% | 48.49% | 48.49% |
| LifeStance Health Group, Inc. (LFST)vs › | $4.70B | 33.56% | 32.27% | 30.18% | 31.09% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.74B | 0.00% | 0.00% | 0.00% | 0.00% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.45B | 75.44% | 66.98% | 64.58% | 67.25% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.44B | 83.86% | 80.36% | 82.01% | 82.83% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.86B | 96.01% | 100.00% | 100.00% | 83.33% |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.86B | 0.00% | 0.00% | 0.00% | 0.00% |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.38B | 0.00% | 0.00% | 0.00% | 0.00% |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.91B | 81.70% | 78.24% | 78.79% | 67.54% |
Gross Margin
18.2%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 18.53% |
| 2026-03-31 | 18.30% |
| 2025-12-31 | 17.99% |
| 2025-09-30 | 17.88% |
| 2025-06-30 | 17.85% |
| 2025-03-31 | 18.55% |
| 2024-12-31 | 19.93% |
| 2024-09-30 | 20.08% |
| 2024-06-30 | 20.32% |
| 2024-03-31 | 20.81% |
| 2023-12-31 | 21.98% |
| 2023-09-30 | 23.26% |
| 2023-06-30 | 23.46% |
| 2023-03-31 | 22.54% |
| 2022-12-31 | 22.50% |
| 2022-09-30 | 21.35% |
| 2022-06-30 | 22.11% |
| 2022-03-31 | 21.94% |
| 2021-12-31 | 22.89% |
| 2021-09-30 | 22.76% |
| 2021-06-30 | 23.13% |
| 2021-03-31 | 21.79% |
| 2020-12-31 | 22.84% |
| 2020-09-30 | 22.28% |
| 2020-06-30 | 22.45% |
| 2020-03-31 | 22.40% |
| 2019-12-31 | 24.37% |
| 2019-09-30 | 22.37% |
| 2019-06-30 | 33.76% |
| 2019-03-31 | 20.61% |
| 2018-12-31 | 33.84% |
| 2018-09-30 | 36.42% |
| 2018-06-30 | 34.11% |
| 2018-03-31 | 32.65% |
| 2017-12-31 | 37.34% |
| 2017-09-30 | 33.50% |
| 2017-06-30 | 31.00% |
| 2017-03-31 | 29.78% |
| 2016-12-31 | 31.09% |
| 2016-09-30 | 27.87% |
| 2016-06-30 | 27.60% |
| 2016-03-31 | 26.94% |
| 2015-12-31 | 29.82% |
| 2015-09-30 | 26.39% |
| 2015-06-30 | 26.25% |
| 2015-03-31 | 26.58% |
| 2014-12-31 | 25.86% |
| 2014-09-30 | 26.25% |
| 2014-06-30 | 26.45% |
| 2014-03-31 | 27.21% |
| 2013-12-31 | 30.75% |
| 2013-09-30 | 32.34% |
| 2013-06-30 | 33.53% |
| 2013-03-31 | 30.91% |
| 2012-12-31 | 33.41% |
| 2012-09-30 | 34.05% |
| 2012-06-30 | 34.02% |
| 2012-03-31 | 34.39% |
| 2011-12-31 | 16.92% |
| 2011-09-30 | 40.08% |
| 2011-06-30 | 39.39% |
| 2011-03-31 | 39.25% |
| 2010-12-31 | 16.12% |
| 2010-09-30 | 17.09% |
| 2010-06-30 | 17.84% |
| 2010-03-31 | 11.61% |
| 2009-12-31 | 12.28% |
| 2009-09-30 | 12.44% |
| 2009-06-30 | 11.68% |
| 2009-03-31 | 11.05% |
| 2008-12-31 | 10.36% |
| 2008-09-30 | 10.04% |
| 2008-06-30 | 10.25% |
| 2008-03-31 | 9.89% |
| 2007-12-31 | 11.38% |
| 2007-09-30 | 11.89% |
| 2007-06-30 | 11.17% |
| 2007-03-31 | 10.99% |
| 2006-12-31 | 10.53% |
| 2006-09-30 | 10.57% |
| 2006-06-30 | 10.30% |
| 2006-03-31 | 10.12% |
| 2005-12-31 | 11.04% |
| 2005-09-30 | 10.79% |
| 2005-06-30 | 10.65% |
| 2005-03-31 | 10.85% |
| 2004-12-31 | 10.55% |
| 2004-09-30 | 10.36% |
| 2004-06-30 | 10.93% |
| 2004-03-31 | 11.46% |
| 2003-12-31 | 11.23% |
| 2003-09-30 | 11.87% |
| 2003-06-30 | 11.95% |
| 2003-03-31 | 11.47% |
| 2002-12-31 | 12.71% |
| 2002-09-30 | 12.97% |
